CHINA STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive Patients: A one-year registry (CHINA STATUS III)

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mr Zhou Du

Peking University First Hospital, Beijing (China)

9 More presentations in this session

Presentation thumbnail

Rates of adherence to modern antihypertensive drugs in resistant hypertension

Doctor E. Kocianova (Olomouc, CZ)

Abstract Slides

Presentation thumbnail

Non-steroid anti-inflammatory drug consumption decrease antihypertensive treatment efficacy in postenopausal women

Professor N. Izmozherova (Yekaterinburg, RU)

Presentation thumbnail

Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

Doctor A. Farcas (Cluj Napoca, RO)

Presentation thumbnail

Long-term treatment with LCZ696 (sacubitril/valsartan) improves cardiac and renal function in stroke-prone spontaneously hypertensive rats

Professor Y. Takeda (Uchinada, JP)

Abstract Slides

Presentation thumbnail

Effect of perindopril/indapamide/amlodipine fixed-dose combination on peripheral and central hemodynamics and vascular wall stiffness parameters in patients with uncontrolled hypertension

Doctor T. Netchessova (Minsk, BY)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 2 - Hypertension treatment old and new

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel

Congress Presentation

Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?

Congress Presentation

Hypertension and glucose

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources